Amla (Emblica officinalis Gaertn.) extract inhibits lipopolysaccharide- induced procoagulant and pro-inflammatory factors in cultured vascular endothelial cells

British Journal of Nutrition

Volumn 110, Issue 12, 2013, Pages 2201-2206

  Pradyumna Rao, Theertham ^a   Okamoto, Takayuki ^b   Akita, Nobuyuki ^b   Hayashi, Tatsuya ^b,c   Kato Yasuda, Naomi ^a   Suzuki, Koji ^b  

^a TAIYO KAGAKU CO LTD   (Japan)

^b MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c MIE PREFECTURAL COLLEGE OF NURSING   (Japan)

Author keywords

Adhesion; Amla; Blood coagulation; Endothelial cells; Inflammation

Indexed keywords

EMBLICA OFFICINALIS EXTRACT; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD CLOTTING; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENDOTOXEMIA; FRUIT; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE ADHERENCE; MALE; MONONUCLEAR CELL; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; VASCULAR ENDOTHELIUM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTICOAGULANTS; CELL ADHESION; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; E-SELECTIN; ENDOTHELIAL CELLS; ENDOTOXEMIA; FRUIT; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MALE; MONOCYTES; PHYLLANTHUS EMBLICA; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, WISTAR; THROMBOPLASTIN; VON WILLEBRAND FACTOR;

EID: 84889244966     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114513001669     Document Type: Article

References (40)

1. Krishnaveni M & Mirunalini S (2010) Therapeutic potential of Phyllanthus emblica (amla): The ayurvedic wonder. J Basic Clin Physiol Pharmacol 21, 93-105.
2. Chen TS, Liou SY & Chang YL (2009) Supplementation of Emblica officinalis (Amla) extract reduces oxidative stress in uremic patients. Am J Chin Med 37, 19-25.
3. Rege NN, Thatte UM & Dahanukar SA (1999) Adaptogenic properties of six rasayana herbs used in Ayurvedic medicine. Phytother Res 13, 275-291.
4. Kumar NP, Annamalai AR & Thakur RS (2009) Antinociceptive property of Emblica officinalis Gaertn (Amla) in high fat diet-fed/low dose streptozotocin induced diabetic neuropathy in rats. Indian J Exp Biol 47, 737-742.
5. Nicolis E, Lampronti I, Dechecchi MC, et al. (2008) Pyrogallol, an active compound from the medicinal plant Emblica officinalis, regulates expression of pro-inflammatory genes in bronchial epithelial cells. Int Immunopharmacol 8, 1672-1680.
6. Sai Ram M, Neetu D, Deepti P, et al. (2003) Cytoprotective activity of amla (Emblica officinalis) against chromium (VI) induced oxidative injury in murine macrophages. Phytother Res 17, 430-433.
7. Steffens S & Mach F (2004) Inflammation and atherosclerosis. Herz 29, 741-748.
8. Levi M & van der Poll T (2010) Inflammation and coagulation. Crit Care Med 38, S26-S34.
9. Sprague AH & Khalil RA (2009) Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol 78, 539-552.
10. Vanhoutte PM, Shimokawa H, Tang EH, et al. (2009) Endothelial dysfunction and vascular disease. Acta Physiol (Oxf) 196, 193-222.
11. Nemerson Y (1988) Tissue factor and hemostasis. Blood 71, 1-8.
12. Wada H, Wakita Y & Shiku H (1995) Tissue factor expression in endothelial cells in health and disease. Blood Coagul Fibrinolysis 6, S26-S31.
13. Ruggeri ZM (2001) Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation. Best Pract Res Clin Haematol 14, 257-279.
14. Palmer DS, Aye MT, Ganz PR, et al. (1994) Adenosine nucleotides and serotonin stimulate von Willebrand factor release from cultured human endothelial cells. Thromb Haemost 72, 132-139.
15. Bochner BS, Luscinskas FW, Gimbrone MA, et al. (1991) Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-Activated human vascular endothelial cells: Contributions of endothelial cell adhesion molecules. J Exp Med 173, 1553-1557.
16. Springer TA (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 76, 301-314.
17. Mantovani A, Bussolino F & Introna M (1997) Cytokine regulation of endothelial cell function: From molecular level to the bedside. Immunol Today 18, 231-240.
18. Deguchi H, Takeya H, Wada H, et al. (1997) Dilazep, an antiplatelet agent, inhibits tissue factor expression in endothelial cells and monocytes. Blood 90, 2345-2356.
19. Kishiwada M, Hayashi T, Yuasa H, et al. (2008) Regulatory mechanisms of C4b-binding protein (C4BP) alpha and beta expression in rat hepatocytes by lipopolysaccharide and interleukin-6. J Thromb Haemost 11, 1858-1867.
20. Patel SS & Goyal RK (2012) Emblica officinalis Geart: A comprehensive review on phytochemistry, pharmacology and ethnomedicinal uses. Res J Med Plant 6, 6-16.
21. Barthakur NN & Arnold NP (1991) Chemical analysis of the emblic (Phyllanthus emblica L.) and its potential as a food source. Sci Hortic 47, 99-105.
22. Ghosal S, Tripati VK & Chauhan S (1996) Active constituents of Emblica officinalis: Part 1 - The chemistry and antioxidant effects of two new hydrolysable tannins, emblicanin A and B. Indian J Chem 3, 941-948.
23. Zhang YJ, Tanaka T, Yang CR, et al. (2001) New phenolic constituents from the fruit juice of Phyllanthas emblica. Chem Pharm Bull (Tokyo) 49, 537-540.
24. Zhang YJ, Abe T, Tanaka T, et al. (2001) Phyllanemblinins A-F, new ellagitannins from Phyllanthus emblica. J Nat Prod 64, 1527-1532.
25. Jaffe EA (1987) Cell biology of endothelial cells. Hum Pathol 18, 234-239.
26. Grandel U & Grimminger F (2003) Endothelial responses to bacterial toxins in sepsis. Crit Rev Immunol 23, 267-299.
27. Volk T & Kox WJ (2000) Endothelium function in sepsis. Inflamm Res 49, 185-198.
28. Calandra T (2001) Pathogenesis of septic shock: Implications for prevention and treatment. J Chemother 1, 173-180.
29. Dauphinee SM & Karsan A (2006) Lipopolysaccharide signaling in endothelial cells. Lab Invest 86, 9-22.
30. Erlich J, Fearns C, Mathison J, et al. (1999) Lipopolysaccharide induction of tissue factor expression in rabbits. Infect Immun 67, 2540-2546.
31. Levi M (2010) The coagulant response in sepsis and inflammation. Hamostaseologie 30, 10-12.
32. Asmawi MZ, Kankaanranta H, Moilanen E, et al. (1993) Anti-inflammatory activities of Emblica officinalis Gaertn leaf extracts. J Pharm Pharmacother 45, 581-584.
33. Ihantola-Vormisto A, Summanen J, Kankaanranta H, et al. (1997) Anti-inflammatory activity of extracts from leaves of Phyllanthus emblica. Planta Med 63, 518-524.
34. Jaijoy K, Soonthornchareonnon N, Panthong A, et al. (2010) Anti-inflammatory and analgesic activities of the water extract from the fruit of Phyllanthus emblica Linn. Int J App Res Nat Prod 3, 28-35.
35. Rao TP, Sakaguchi N, Juneja LR, et al. (2005) Amla (Embica officianalis Gaertn.) extracts reduce oxidative stress in streptozotocin-induced diabetic rats. J Med Food 8, 362-368.
36. Yokozawa T, Kim HY, Kim HJ, et al. (2007) Amla (Emblica officinalis Gaertn.) prevents dyslipidaemia and oxidative stress in the ageing process. Br J Nutr 97, 1187-1195.
37. Baliga MS & Dsouza JJ (2011) Amla (Emblica officinalis Gaertn), a wonder berry in the treatment and prevention of cancer. Eur J Cancer Prev 20, 225-239.
38. Reddy VD, Padmavathi P, Gopi S, et al. (2010) Protective effect of Emblica officinalis against alcohol-induced hepatic injury by ameliorating oxidative stress in rats. Indian J Clin Biochem 25, 419-424.
39. Akhtar MS, Ramzan A, Ali A, et al. (2011) Effect of Amla fruit (Emblica officinalis Gaertn.) on blood glucose and lipid profile of normal subjects and type 2 diabetic patients. Int J Food Sci Nutr 62, 609-616.
40. Saeed S & Tariq P (2007) Antibacterial activities of Emblica officinalis and Corandrum stivum against gram negative urinary pathogens. Pak J Pharm Sci 20, 32-35.